Health
Study reveals new mutations that make cancer resistant to KRAS-targeted therapies – News-Medical.Net
A gene called KRAS is one of the most commonly mutated genes in all human cancers, and targeted drugs that inhibit the protein expressed by mutated KRAS have shown…
A gene called KRAS is one of the most commonly mutated genes in all human cancers, and targeted drugs that inhibit the protein expressed by mutated KRAS have shown promising results in clinical trials, with potential approvals by the U.S. Food and Drug Administration anticipated later this year.
Unfortunately, cancer cells often develop additional mutations that make them resistant to such targeted drugs, resulting in disease relapse. Now researchers led by a team at Massachusetts General Hospital…
-
General15 hours agoAFL gives teams finishing 10th chance to win premiership through wildcard round in finals
-
General11 hours agoPrincess Anne remembers Porepunkah police officers in wreath-laying ceremony in Melbourne
-
Noosa News5 hours ago‘Just want to know he’s safe’: Family’s German Shepherd asleep in back of stolen ute
-
Noosa News13 hours agoMan allegedly exposed himself to teen girls in Newstead, Springfield; Dingo snatches shark on K’gari; BBC boss and news chief quit over Trump video outrage